Immunome Q2 EPS $(0.60) Misses $(0.39) Estimate, Sales $2.36M Miss $2.55M Estimate
Author: Benzinga Newsdesk | August 12, 2024 04:02pm
Immunome (NASDAQ:
IMNM) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.39) by 53.85 percent. This is a 30.43 percent decrease over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $2.36 million which missed the analyst consensus estimate of $2.55 million by 7.29 percent. This is a 44.55 percent decrease over sales of $4.26 million the same period last year.
Posted In: IMNM